Ledger.Open graph →
SEC Form D · filed March 14, 2023

Adze Biotechnology Inc

Offering
$15.0M
Sold
$6.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Coral Gables, FL
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (17)

Brendan P. Kenny · Edmonton, Alberta, CanadaDirectorGloria J. Olivier · Rochester, MNDirectorG. P. Sage, Ii · Kalamazoo, MIDirectorGabriel P. Raviv · Glenview, ILDirectorKenneth J. Templin · Oak Park, ILExecBela Szigethy · NEW YORK, NYDirectorStewart Kohl · CLEVELAND, OHDirectorTerrence A. Avella · New York, NYExecDavid Reiss · NEW YORK, NYDirectorJonathan S. Beach · The Woodlands, TXDirectorSidney Hopps · Miami, FLExec · DirectorBernard Lawrence · St Peter Port, Y7ExecSateeta N. Jeewoolall Jessoo · Trianon, O4DirectorSPV Solutions Management I LLC · Salt Lake City, UTDirectorRichard Robb · New York, NYDirectorRoger Renaud · Montreal, Quebec, CanadaDirectorSidney Hopps · Miami, FLExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗